Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial

Dean A. Fennell, Amy King, Seid Mohammed, Amy Branson, Cassandra Brookes, Liz Darlison, Alan G. Dawson, Aarti Gaba, Margaret Hutka, Bruno Morgan, Adrian Nicholson, Cathy Richards, Peter Wells-Jordan, Gavin J. Murphy, Anne Thomas, Dean A. Fennell, Amy King, Seid Mohammed, Amy Branson, Cassandra Brooks, Liz Darlison, Alan G. Dawson, Aarti Gaba, Margaret Hutka, Bruno Morgan, Adrian Nicholson, Cathy Richards, Peter Wells-Jordan, Gavin J. Murphy, Anne Thomas, Sarah Anthony, Vina Bhundia, Caroline Cowley, Charlotte Poile, Molly Scotland, Charlotte Poile, Molly Scotland